ABBOTT LABORATORIES (ABT)

3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years

These are income stocks you can buy and hold forever.

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.

2 Dividend Kings That Would Have Doubled Your Money in 5 Years

You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

You'll also like these stocks for their track record of earnings growth.

Noteworthy Friday Option Activity: RKT, NET, ABT

These S&P500 stocks are moving in today's session

Top S&P500 movers in Friday's session

Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial

Lawyers for the plaintiff had been arguing for a $6.2 billion verdict.

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.

Friday's pre-market session: top gainers and losers in the S&P500 index

Reckitt Surges Most in 24 Years After Baby Formula Trial Win

Shares of Reckitt Benckiser Group Plc jumped the most in 24 years following a US jury verdict that cleared it and Abbott Laboratories over claims they hid potential risks of their premature-infant formulas.

Abbott, Reckitt Unit Defeat Claims in Baby Formula Trial

Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.

3 Dividend Growth Stocks You Can Buy and Hold Forever

These healthcare stocks have fantastic dividend track records.

ABT December 6th Options Begin Trading

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

/PRNewswire/ -- Abbott (NYSE: ABT) today announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart...

Beat the Nasdaq With This Cash-Gushing Dividend Stock

The company is performing well despite recently losing its biggest growth driver.

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

These companies' longtime shareholders have generally been rewarded.

Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review

The Dow Jones and S&P 500 hit highs as they extended weekly win streaks.

3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now

These stocks could deliver big over the long term.

See Which Of The Latest 13F Filers Holds Abbott Laboratories

Is Abbott Laboratories Stock a Buy?

The healthcare stock is lagging the market this year.

Why Abbott Laboratories Stock Was a Winner on Wednesday

Investors bumped its shares higher following a decent, if unspectacular, earnings report.

Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript

ABT earnings call for the period ending September 30, 2024.

Abbott Labs Earnings Edge Past Q3 Views, Led By Medical Devices

Medical devices led organic sales growth.

Abbott slightly raises profit forecast on strong medical device sales

The company now expects a full-year profit of $4.64 to $4.70 per share, with the midpoint a tad higher than that of its earlier forecast of $4.61 to $4.71 per share. On an adjusted basis, the company's quarterly profit of $1.21 per share beat analysts' average expectations of $1.20 per share, according to estimates compiled by LSEG.

Abbott Narrows 2024 Forecast as Medical Devices Drive Growth

Abbott Laboratories narrowed its full-year profit outlook as strong demand for medical devices, particularly those used by patients with diabetes, continued driving growth.